Atlantic League, FerryHawks announce new digital broadcasting partnership

The Atlantic League of Professional Baseball and the Staten Island FerryHawks have announced a new digital broadcasting ...

Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) “Research of the Year” Roundup

Launch-HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant ...
Yahoo Finance

Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension

RADNOR, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...
TCTMD

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

BOSTON, MA—It’s a surprise turnaround for a trial that once was poised to put the brakes on renal denervation once and for all. Long-term follow-up of hypertension patients treated with the Symplicity ...
Medscape

ADVANCE-HTN Shows Benefit of Lorundrostat in Resistant Hypertension

CHICAGO — The addition of lorundrostat, an investigational drug, to the treatment regimen of people with well-treated but uncontrolled and resistant hypertension could be beneficial, new data show.
Medscape

Positive Topline Results for Lorundrostat in Hypertension

Lorundrostat, a hypertension drug from Mineralys Therapeutics, has shown positive results in two pivotal trials for the treatment of uncontrolled or resistant hypertension the company announced on ...
HealthLeaders Media

Nurse Leaders Issue a Call to Action to Fight Hypertension and Cardiovascular Disease

Nurses from all sectors can take a leading role in preventing and controlling hypertension, thereby preventing high rates of cardiovascular disease, new study says. With hypertension (HTN) as a ...
TCTMD

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

SAN DIEGO, CA—Renal denervation using ultrasound may be more effective than radiofrequency ablation for lowering blood pressure in patients with resistant hypertension, a preliminary head-to-head ...
Healio

Novel agent targeting aldosterone lowers blood pressure for adults with resistant hypertension

Please provide your email address to receive an email when new articles are posted on . Once-daily lorundrostat safely lowered 24-hour systolic BP compared with placebo in a phase 2 trial. A ...
Yahoo Finance

SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years

Company commits to advancing clinical data for Symplicity™ with the SPYRAL Gemini clinical trial and expansion of the GSR-DEFINE clinical trial GALWAY, Ireland and WASHINGTON, Oct. 28, 2024 ...
Nasdaq

Mineralys Therapeutics Announces Positive Phase 3 Launch-HTN Trial Results for Lorundrostat in Uncontrolled Hypertension

Mineralys Therapeutics announced the positive results of its Launch-HTN trial, the largest study of an aldosterone synthase inhibitor for patients with uncontrolled or treatment-resistant hypertension ...